WANG Ping,WANG Ziyue,HUANG Kun,et al.Risk Factors of Psoriatic Arthritis and its Molecular and Cellular Mechanisms[J].The Chinese Journal of Dermatovenereology,2021,(01):96-441149a5-38a4-4f92-b692-d32f3860688f/pdf.[doi:10.13735/j.cjdv.1001-7089.202003078]





Risk Factors of Psoriatic Arthritis and its Molecular and Cellular Mechanisms
Department of Dermatology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
银屑病关节炎 早期预防 风险因素 分子机制 细胞机制
Psoriatic arthritis Early prevention Risk factors Molecular mechanisms Cellular mechanisms
R 758.63
银屑病关节炎(psoriatic arthritis,PsA)是一种与银屑病相关的慢性炎症性关节病,主要表现为外周关节炎、附着点炎、指(趾)炎和脊柱关节炎,其临床表现和治疗反应具有较高的异质性,表现形式多样、复杂,且有一定的致残率,严重影响患者的身心健康、生活质量和工作能力。早期诊断和干预其病程可显著改善PsA临床前阶段的临床指标和影像学结果,因此,早期识别、治疗PsA对于改善患者长期预后非常重要。本文将就PsA的发病风险因素、早期预防策略及单纯皮肤受累的银屑病(cutaneous psoriasis,PsC)向PsA转变的分子细胞学机制进行综述。
Psoriatic arthritis(PsA)is a chronic inflammatory joint disease associated with psoriasis. It is mainly manifested in peripheral arthritis,enthesitis,dactylitis,and spondyloarthritis. The clinical manifestation and treatment response of PsA are highly heterogeneous,and there is a certain rate of disability,which seriously affects the physical and mental health,and work ability of patients. Early diagnosis and intervention of its course can significantly improve the clinical indicators and imaging results of PsA in the preclinical stage. Therefore,early identification and treatment of PsA is very important to improve the long-term prognosis of patients. This article reviews the risk factors for PsA,early prevention strategies,and the molecular and cytological mechanisms of cutaneous psoriasis(PsC)to PsA.


[1] Thorarensen SM,Lu N,Ogdie A,et al.Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis[J].Ann Rheum Dis,2017,76(3):521-525.
[2] Hsieh J,Kadavath S,Efthimiou P. Can traumatic injury trigger psoriatic arthritis? A review of the literature[J].Clin Rheumatol,2014,33(5):601-608.
[3] Ng J,Tan AL,Mcgonagle D. Unifocal psoriatic arthritis development in identical twins following site specific injury:evidence supporting biomechanical triggering events in genetically susceptible hosts[J].Ann Rheum Dis,2015,74(5):948-949.
[4] Tinazzi I,Mcgonagle D,Aydin SZ,et al.‘Deep Koebner' phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis[J].Ann Rheum Dis,2018,77(6):922-925.
[5] Jacques P,Lambrecht S,Verheugen E,et al.Proof of concept:enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells[J].Ann Rheum Dis,2014,73(2):437-445.
[6] Pezzolo E,Naldi L. The relationship between smoking,psoriasis and psoriatic arthritis[J].Expert Rev Clin Immunol,2019,15(1):41-48.
[7] Tey HL,Ee HL,Tan AS,et al.Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis[J].J Dermatol,2010,37(5):426-430.
[8] Wu S,Cho E,Li W Q,et al.Alcohol intake and risk of incident psoriatic arthritis in women[J].J Rheumatol,2015,42(5):835-840.
[9] Eder L,Haddad A,Rosen CF,et al.The incidence and risk factors for psoriatic arthritis in patients with psoriasis:a prospective cohort study[J].Arthritis Rheumatol,2016,68(4):915-923.
[10] Fitzgerald O,Haroon M,Giles JT,et al.Concepts of pathogenesis in psoriatic arthritis:genotype determines clinical phenotype[J].Arthritis Res Ther,2015,17(1):115-125.
[11] Stuart PE,Nair RP,Tsoi LC,et al.Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture[J].Am J Hum Genet,2015,97(6):816-836.
[12] Aterido A,Canete JD,Tornero J,et al.Genetic variation at the glycosaminoglycanmetabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis[J].Ann Rheum Dis,2019,78(3):355-364.
[13] Yan D,Ahn R,Leslie S,et al.Clinical andgenetic risk factors associated with psoriatic arthritis among patients with psoriasis[J].Dermatol Ther(Heidelb),2018,8(4):593-604.
[14] Ogdie A,Weiss P. Theepidemiology of psoriatic arthritis[J].Rheum Dis Clin North Am,2015,41(4):545-568.
[15] Daien CI,Sellam J. Obesity and inflammatory arthritis:impact on occurrence,disease characteristics and therapeutic response[J].RMD Open,2015,1(1):e000012.
[16] Wu S,Li WQ,Han J,et al.Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women[J].Arthritis Rheumatol,2014,66(2):304-310.
[17] Tsuruta N,Imafuku S,Narisawa Y. Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients[J].J Dermatol,2017,44(12):1349-1352.
[18] Egeberg A,Khalid U,Gislason GH,et al.Association of psoriatic disease with uveitis:a danish nationwide cohort study[J].JAMA Dermatol,2015,151(11):1200-1205.
[19] Dalmady S,Kemeny L,Antal M,et al.Periodontitis:a newly identified comorbidity in psoriasis and psoriatic arthritis[J].Expert Rev Clin Immunol,2020,16(1):101-108.
[20] Scher JU,Ogdie A,Merola JF,et al.Preventing psoriatic arthritis:focusing on patients with psoriasis at increased risk of transition[J].Nat Rev Rheumatol,2019,15(3):153-166.
[21] Panayi GS. Immunology of psoriasis and psoriatic arthritis[J].Baillieres Clin Rheumatol,1994,8(2):419-427.
[22] Taams LS,Steel K,Srenathan U,et al.IL-17 in the immunopathogenesis of spondyloarthritis[J].Nat Rev Rheumatol,2018,14(8):453-466.
[23] Reinhardt A,Yevsa T,Worbs T,et al.Interleukin-23-dependent gamma/delta T cells produce interleukin-17 and accumulate in the enthesis,aortic valve,and ciliary body in mice[J].Arthritis Rheumatol,2016,68(10):2476-2486.
[24] Wang Z,Tan J,Lei L,et al.The positive effects of secreting cytokines IL-17 and IFN-gamma on the early-stage differentiation and negative effects on the calcification of primary osteoblasts in vitro[J].Int Immunopharmacol,2018,57:1-10.
[25] Ryder LR,Bartels EM,Woetmann A,et al.FoxP3 mRNA splice forms in synovial CD4+ T cells in rheumatoid arthritis and psoriatic arthritis[J].APMIS,2012,120(5):387-396.
[26] Sugiyama H,Gyulai R,Toichi E,et al.Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis:mechanism underlying unrestrained pathogenic effector T cell proliferation[J].J Immunol,2005,174(1):164-173.
[27] Scher JU,Littman DR,Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases[J].Arthritis Rheumatol,2016,68(1):35-45.
[28] Scher JU,Ubeda C,Artacho A,et al.Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis,resembling dysbiosis in inflammatory bowel disease[J].Arthritis Rheumatol,2015,67(1):128-139.
[29] Ritchlin CT,Haas-Smith SA,Li P,et al.Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis[J].J Clin Invest,2003,111(6):821-831.
[30] Takahashi S,Fukuda M,Mitani A,et al.Follicular dendritic cell-secreted protein is decreased in experimental perio-dontitis concurrently with the increase of interleukin-17 expression and the Rankl/Opg mRNA ratio[J].J Periodontal Res,2014,49(3):390-397.
[31] Sato K,Suematsu A,Okamoto K,et al.Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction[J].J Exp Med,2006,203(12):2673-2682.
[32] Abji F,Pollock RA,Liang K,et al.Briefreport:CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis[J].Arthritis Rheumatol,2016,68(12):2911-2916.
[33] Cretu D,Gao L,Liang K,et al.Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers[J].Arthritis Care Res(Hoboken),2018,70(3):454-461.
[34] Cretu D,Liang K,Saraon P,et al.Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers[J].Clin Proteomics,2015,12(1):1-8.


 WANG Qian,LIU Wei,ZHANG Li-xia,et al.The Relationship of Neutrophil to Lymphocyte Ratio with Psoriasis Vulgaris and Psoriasis Arthritis[J].The Chinese Journal of Dermatovenereology,2016,(01):1017.[doi:10.13735/j.cjdv.1001-7089.201601143]


[基金项目] 国家自然科学基金(8187120590; 81972942) [通信作者] 陈爱军,E-mail:cajhx@aliyun.com
更新日期/Last Update: 2021-01-10